Article Text

PDF
PP 024
A SYSTEMS PHARMACOLOGY MODEL TO EXPLAIN DEVELOPMENTAL DIFFERENCES IN SENSITIVITY TO DRUG-INDUCED QT PROLONGATION
  1. Verena Gotta1,
  2. Marc Pfister2,
  3. John van den Anker2,
  4. Piet van der Graaf1
  1. 1Leiden Academic Center of Drug Research (LACDR), Leiden University, Leiden, The Netherland
  2. 2University Children's Hospital Basel, University of Basel, Basel, Switzerland

Abstract

Background Neonates have been reported to be more sensitive to drugs prolonging the QT-interval than adults. As explanation a developmental change in myocardial ion-channel density has been proposed. Here we explore changes in ion-channel density using a mechanistic pharmacodynamic model and clinical sotalol literature data.

Materials and Methods The applied model relates in vitro and in vivo drug potency (regarding IKr-receptor occupancy and QTc-prolongation, respectively) by a system-specific transducer function. We characterized this function first for preclinical dog and in vitro data (moxifloxacin, sotalol, dofetilide). From a corresponding dofetilide model in adults we derived scaling factors for the system-specific parameters (maximal in vivo QTc-effect Em,dog/Em,adults, transducer ratio τ,dog/τ,adults; τ is proportional to the receptor density in vivo). The derived relationship was used to predict clinical sotalol pharmacodynamics in adults. Literature data was used to evaluate this scaling approach. Simulations of different τ values were performed to explore pharmacodynamic differences in neonates.

Results In adults, the agonistic activity of dofetilide was higher than in dogs (τ,adults≈2x τ,dogs), while the estimated maximal in vivo QTc-prolongation was similar (Em≈27% from baseline). This relationship could also predict clinical sotalol pharmacodynamics in adults and children. The steeper PD profile in neonates could be explained by a higher IKr-receptor density (τ, neonates≈2x τ, adults).

Conclusion This model-based approach allowed to integrate and scale in vitro and in vivo (preclinical, clinical adult and neonate) drug effects on the QTc-interval. The preliminary results confirm the hypothesis that IKr-receptor density is higher (≈2 times) in neonates than in adults and children.

  • ESDP

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.